| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/07/2012 | CA2819416A1 Peptide scaffold design |
| 06/07/2012 | CA2819356A1 Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly |
| 06/07/2012 | CA2819246A1 Liquid viral formulations |
| 06/07/2012 | CA2819236A1 Lyophilized viral formulations |
| 06/07/2012 | CA2819187A1 Covalently dimerized bivalent binding agents |
| 06/07/2012 | CA2818173A1 Low affinity blood brain barrier receptor antibodies and uses therefor |
| 06/07/2012 | CA2817543A1 Immunomodulatory methods and systems for treatment and/or prevention of hypertension |
| 06/07/2012 | CA2816426A1 Alaninyl maytansinol antibody conjugates |
| 06/07/2012 | CA2812348A1 Egfr antagonist for the treatment of heart disease |
| 06/06/2012 | EP2460878A1 Orf7 deficient varicella virus, vaccine comprising the virus and use thereof |
| 06/06/2012 | EP2460832A2 TWEAK binding antibodies |
| 06/06/2012 | EP2460831A2 Tweak binding antibodies |
| 06/06/2012 | EP2460830A2 IL-18 binding proteins |
| 06/06/2012 | EP2460829A2 IL-18 binding proteins |
| 06/06/2012 | EP2460824A1 Hypoallergenic polypeptides for the treatment of house dust mite allergy |
| 06/06/2012 | EP2460821A2 PCV2 immunogenic compositions and methods of producing such compositions |
| 06/06/2012 | EP2460820A2 PCV2 immunogenic compositions and methods of producing such compositions |
| 06/06/2012 | EP2460819A2 PCV2 immunogenic compositions and methods of producing such compositions |
| 06/06/2012 | EP2460818A2 PCV2 immunogenic compositions and methods of producing such compositions |
| 06/06/2012 | EP2460817A2 PCV2 immunogenic compositions and methods of producing such compositions |
| 06/06/2012 | EP2460816A2 PCV2 immunogenic compositions and methods of producing such compositions |
| 06/06/2012 | EP2460813A1 A beta immunogenic peptide carrier conjugates and methods of producing same |
| 06/06/2012 | EP2460538A1 Cancer metastasis inhibitor |
| 06/06/2012 | EP2460537A1 Methods for treating conditions associated with MASP-2 dependent complement activation |
| 06/06/2012 | EP2460536A1 New virulence factors of Streptococcus pneumoniae |
| 06/06/2012 | EP2460535A1 New virulence factors of Streptococcus pneumoniae |
| 06/06/2012 | EP2460534A1 Flagellin related polypeptides and uses thereof |
| 06/06/2012 | EP2460533A2 Yeast-based therapeutic for chronic hepatitis C infection |
| 06/06/2012 | EP2459722A1 Reverse genetics systems |
| 06/06/2012 | EP2459709A2 High yield yellow fever virus strain with increased propagation in cells |
| 06/06/2012 | EP2459708A1 H. pylori lipopolysaccharide outer core epitope |
| 06/06/2012 | EP2459594A1 Fully human antibodies to btla |
| 06/06/2012 | EP2459592A1 High affinity human antibodies to human angiopoietin-2 |
| 06/06/2012 | EP2459591A1 Inhibition of tumor metastasis using bv8- or g-csf-antagonists |
| 06/06/2012 | EP2459222A1 Sticky soft gel for treating poultry |
| 06/06/2012 | EP2459217A1 Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids |
| 06/06/2012 | EP2459216A2 Immunogenic compositions including tlr activity modulators |
| 06/06/2012 | EP2459215A1 Method and kit for treating nicotine addiction |
| 06/06/2012 | EP2459214A1 Antigenic tau peptides and uses thereof |
| 06/06/2012 | EP2459204A1 Mycobacterium mutants for vaccines with improved protective efficacy |
| 06/06/2012 | EP2459191A1 Mtor inhibitor and angiogenesis inhibitor combination therapy |
| 06/06/2012 | EP2459167A2 Subcutaneous anti-her2 antibody formulation |
| 06/06/2012 | EP2261374B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having Class I membrane fusogenic envelope proteins |
| 06/06/2012 | EP2197486B1 Reduction of concomitant infections in pigs by the use of pcv2 antigen |
| 06/06/2012 | EP2128261B1 A recombinant adenovirus comprising recombinant khp53 gene and preparation method and uses thereof |
| 06/06/2012 | EP2115003B1 Human antibodies to human delta like ligand 4 |
| 06/06/2012 | EP2061814B1 Antibodies and immunoconjugates and uses therefor |
| 06/06/2012 | EP2004693B1 Compositions and methods of use for antibodies of c-met |
| 06/06/2012 | EP1967209B1 Therapeutic agent for prostate cancer |
| 06/06/2012 | EP1863940B1 Method of risk management for patients undergoing natalizumab treatment |
| 06/06/2012 | EP1860951B1 Animal model for porcine helicobacter infection |
| 06/06/2012 | EP1846767B1 Kid31 and antibodies that bind thereto |
| 06/06/2012 | EP1628530B1 Methods and compositions for the prevention and treatment of sepsis |
| 06/06/2012 | EP1616575B1 Method for treating inflammation |
| 06/06/2012 | EP1575526B1 Dna vaccines encoding heat shock proteins |
| 06/06/2012 | EP1490104B1 Protein-based streptococcus pneumoniae vaccines |
| 06/06/2012 | EP1463558B1 Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same |
| 06/06/2012 | DE112010003137T5 Prophylaxe gegen krebsmetastasierung Prophylaxis against cancer metastasis |
| 06/06/2012 | CN1942205B Antigen-drug vehicle enabling transmucosal and transdermal administration and method of inducing mucosal immunity, mucosal vaccine and DDS using the same |
| 06/06/2012 | CN1409725B Peptide minics of conserved gonococcal epitopes and methods and compositions using them |
| 06/06/2012 | CN102485753A Human derived heavy chain variable region possessing human vascular endothelial growth factor binding activity |
| 06/06/2012 | CN102485749A Swine fever synthesized peptide vaccine and preparation method thereof |
| 06/06/2012 | CN102485274A Preparation method and use of poly(lactic-co-glycolic acid) (PLGA) microspheres as nucleic acid vaccine vectors |
| 06/06/2012 | CN102485273A HIV-1 liposome vaccine |
| 06/06/2012 | CN101979513B Duck-origin paramyxovirus attenuated lapinized Chineses (LC) strain and application thereof to the preparation of vaccines |
| 06/06/2012 | CN101863965B Helicobacter pylori urease B antigenic epitope polypeptide and application thereof |
| 06/06/2012 | CN101845455B Corn expression vector of Hepatitis B virus L gene and application thereof |
| 06/06/2012 | CN101829337B Immune composition aiming at Neisseria meningitidis |
| 06/06/2012 | CN101745111B Method for restraining infiltration and metastasis of breast cancer cells by using target CCL 18 and application thereof |
| 06/06/2012 | CN101745107B Recombinant replication-defective adenoviral vector H5N1 subtype influenza genetic engineering vaccine |
| 06/06/2012 | CN101709080B Synthetic peptide vaccine for resisting porcine circovirus and preparation method thereof |
| 06/06/2012 | CN101690812B Concentrated freeze-dried yolk antibody composite preparation for Newcastle disease-infectious bursal disease and preparation process thereof |
| 06/06/2012 | CN101643500B Asia I synthetic peptide vaccine of foot and mouth disease |
| 06/06/2012 | CN101628932B Bird flu synthetic peptide vaccine and preparation method thereof |
| 06/06/2012 | CN101437834B Modulation of cytokine signaling regulators and applications for immunotherapy |
| 06/06/2012 | CN101386642B Expression of vibrio alginolyticus outer membrane protein VA0760 and application thereof as vaccine component |
| 06/05/2012 | US8193415 Plant expressing mammalian β1,4-galactosyltransferase and β1,3-glucuronyltransferase |
| 06/05/2012 | US8193332 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
| 06/05/2012 | US8193326 Nucleotide sequences coding oncogenic polypeptides for use in generating vaccines to prevent and treat cell proliferative disorders; genetic vaccines |
| 06/05/2012 | US8193321 Multispecific antibodies |
| 06/05/2012 | US8193319 Antibodies to IL-17A |
| 06/05/2012 | US8193185 Administering a tryptanthrin compound, e.g., 8-nitroindolo[2,1-b]quinazoline-6,12-dione, to potentiate the immune response to an antigen; immunostimulants; small molecule immune potentiators; immunotherapy for infectious diseases; anticarcinogenic agents; vaccine adjuvant compositions and kits |
| 06/05/2012 | US8192991 Methods of eliciting or boosting a cellular immune response |
| 06/05/2012 | US8192979 Compositions, methods and devices for preparing less painful Botulinum toxin formulations |
| 06/05/2012 | US8192927 Human bind molecules capable of neutralizing influenza virus h5n1 and uses thereof |
| 06/05/2012 | US8192747 Comprising a rotavirus antigen, a sugar and a carboxylate, between pH 5.0 and pH 8.0 and no phosphate or less than 5 mM phosphate; for human infants |
| 06/05/2012 | US8192746 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition |
| 06/05/2012 | US8192744 Drug for treating states related to the inhibition of angiogenesis and/or endothelial cell proliferation |
| 06/05/2012 | US8192743 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 06/05/2012 | US8192742 Method of inhibiting complement activation with human anti-factor C3 antibodies and use thereof |
| 06/05/2012 | US8192741 Method of treating rheumatoid arthritis with an anti-IL-6R antibody |
| 06/05/2012 | US8192740 Pharmaceutical composition comprising anti-GRP78 antibody as active ingredient |
| 06/05/2012 | US8192739 Fusion proteins containing recombinant cytotoxic RNAses |
| 06/05/2012 | US8192738 Targeted antibodies directed to DLL4 |
| 06/05/2012 | US8192737 Identification and engineering of antibodies with variant Fc regions and methods of using same |
| 06/05/2012 | US8192736 Remedy for endometriosis |
| 06/05/2012 | US8192735 Method for modulating appetite |
| 06/05/2012 | US8192720 Compositions and methods for detection, prevention, and treatment of anthrax and other infectious diseases |
| 06/05/2012 | CA2571019C 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 06/05/2012 | CA2561826C Linear single chain recombinant anti-cea/cd3/cd28 trispecific antibody |